Neurodegenerative disorders are one of the most debilitating, chronic, and often irreversible
disorders of the brain and have gained a widespread attention of researchers. Since current …

Alzheimer's disease (AD) imparts a neurodegenerative impact on mental ability, dementia,
and behavioral alterations that have been observed in the ten to twenty years before the …

In this study, nanofibers against pro dimorphic fungal sessile growth were developed.
Quercetin was successfully encapsulated within poly (d, l-lactide-co-glycolide)–poly (ε …

Alzheimer's disease (AD) is a serious health concern, affecting millions of people globally,
which leads to cognitive impairment, dementia, and inevitable death. There is still no …

This study was aimed at developing a polymeric drug delivery system for a steroidal
aromatase inhibitor, exemestane (exe) intended for sustained targeted delivery of drug …

Rivastigmine is an acetylcholinesterase (AchE) and butyrylcholinesterase (BchE) inhibitor
drug approved by the US Food and Drug Administration (FDA) for the treatment of mild to …

A novel albumin polymer hybrid with a core–shell structure was designed to target delivery
of bufalin, which is an antineoplastic monomer with serious cardiotoxicity. The sheath layer …

Background: Drug repurposing is an innovative approach as it provides new indications for
already approved and established drugs. Due to high failure rates and cost involved in …

Polymeric microspheres containing aceclofenac were prepared by single emulsion (oil-in-
water) solvent evaporation method using response surface methodology (RSM) …

Currently Alzheimer's disease and schizophrenia are both well-established neuropsychiatric
diseases. Nonetheless, the treatment of these disorders is not unanimous and fully effective …